{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+label&page=19", "query": { "intervention": "Control label", "page": 19 }, "page_size": 10 }, "pagination": { "page": 19, "page_size": 10, "total_count": 3335, "total_pages": 334, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+label&page=20&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+label&page=18&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T00:59:32.929Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01596920", "title": "Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Foot Ulcers" ], "interventions": [ { "name": "Tissue", "type": "OTHER" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Osiris Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 97, "start_date": "2012-04", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2014-04-09", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 15, "location_summary": "Montgomery, Alabama • Glendale, Arizona • Encinitas, California + 12 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Inverness", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01596920" }, { "nct_id": "NCT00040391", "title": "A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Neoplasms", "Diarrhea" ], "interventions": [ { "name": "Investigational drug", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "5-fluorouracil", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2002-06", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 28, "location_summary": "Little Rock, Arkansas • Anaheim, California • Concord, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "Gilroy", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00040391" }, { "nct_id": "NCT02217410", "title": "CCFZ533X2201 - PoC Study in de Novo Renal Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "CFZ533", "type": "BIOLOGICAL" }, { "name": "Tacrolimus (Tac)", "type": "DRUG" }, { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "Corticosteroids (CS)", "type": "DRUG" }, { "name": "anti-IL2 Induction", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2015-02-05", "completion_date": "2017-11-29", "has_results": true, "last_update_posted_date": "2021-09-28", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 6, "location_summary": "Aurora, Colorado • Baltimore, Maryland • Ann Arbor, Michigan + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Livingston", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02217410" }, { "nct_id": "NCT04075682", "title": "Cigarette Pack Inserts for Smoking Cessation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation" ], "interventions": [ { "name": "Inserts with efficacy messages", "type": "OTHER" }, { "name": "Pictorial warnings on packs", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 387, "start_date": "2019-08-01", "completion_date": "2021-06-29", "has_results": true, "last_update_posted_date": "2024-05-13", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 2, "location_summary": "Ithaca, New York • Columbia, South Carolina", "locations": [ { "city": "Ithaca", "state": "New York" }, { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04075682" }, { "nct_id": "NCT06930625", "title": "A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acromegaly" ], "interventions": [ { "name": "Debio 4126", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2025-11-26", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 10, "location_summary": "Los Angeles, California • Chicago, Illinois • Boston, Massachusetts + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT06930625" }, { "nct_id": "NCT01994291", "title": "A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Macular Edema, Diabetic" ], "interventions": [ { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PF-04634817", "type": "DRUG" }, { "name": "Masked Sham Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2013-11", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2016-10-17", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 33, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Arcadia, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01994291" }, { "nct_id": "NCT05003687", "title": "Safety and Tolerability of Lu AG06474 in Healthy Young Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Lu AG06474", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 79, "start_date": "2021-08-04", "completion_date": "2022-12-22", "has_results": false, "last_update_posted_date": "2023-01-09", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05003687" }, { "nct_id": "NCT00089492", "title": "A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Optimized Background ARVs", "type": "DRUG" }, { "name": "enfuvirtide [Fuzeon]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 64, "start_date": "2004-07", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 21, "location_summary": "Hobson City, Alabama • Fountain Valley, California • Los Angeles, California + 16 more", "locations": [ { "city": "Hobson City", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00089492" }, { "nct_id": "NCT01098981", "title": "Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Ischemic Stroke" ], "interventions": [ { "name": "Transcranial ultrasound as an adjunctive therapy to tPA", "type": "DEVICE" }, { "name": "Standard of care tPA therapy for acute ischemic stroke", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Cerevast Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 675, "start_date": "2013-05", "completion_date": "2015-04", "has_results": false, "last_update_posted_date": "2015-04-07", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 1, "location_summary": "Redmond, Washington", "locations": [ { "city": "Redmond", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01098981" }, { "nct_id": "NCT02027428", "title": "Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Squamous Cell Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Abraxane (Induction)", "type": "DRUG" }, { "name": "Carboplatin (Induction)", "type": "DRUG" }, { "name": "Abraxane (Maintenance)", "type": "DRUG" }, { "name": "Best Supportive Care (Maintenance)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 427, "start_date": "2014-02-11", "completion_date": "2019-08-01", "has_results": true, "last_update_posted_date": "2020-08-17", "last_synced_at": "2026-10-22T00:59:32.929Z", "location_count": 91, "location_summary": "Huntsville, Alabama • Glendale, Arizona • Tucson, Arizona + 73 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02027428" } ] }